One implication of the data presented in this paper is that inhibiting BTK in monocytes and neutrophils, as an off‐target drug effect, could result in their inefficient recruitment of innate immune cells to sites of ongoing infection and result in reduced pathogen clearance. This evidence concerns the gene BTK and infection.